Evermine50 Everolimus-Eluting Coronary Stent System

The cobalt-chromium platform offers superior radial strength and conformability, while the ultra-thin strut design minimizes vessel injury, promotes rapid endothelialization, and reduces the risk of restenosis and thrombosis, enhancing overall clinical performance.

The durable polymer coating ensures controlled drug release and minimizes inflammatory response, improving biocompatibility and reducing the risk of late stent thrombosis and neoatherosclerosis, leading to improved long-term safety and efficacy.

The Evermine50™ stent system provides enhanced deliverability and lesion access due to its flexible design and low crossing profile. This facilitates precise stent placement, reduces procedural complexity, and expands treatment options for challenging lesions, ultimately improving surgical efficiency.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the Evermine50 Everolimus-Eluting Coronary Stent System, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The Evermine50 Everolimus-Eluting Coronary Stent System is constructed using Cobalt-Chromium, ensuring high biocompatibility and durability.